UK markets closed

Crystalvue Medical Corporation (6527.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
80.30+0.90 (+1.13%)
At close: 01:30PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 2.01B
Enterprise value 1.75B
Trailing P/E 19.41
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.44
Price/book (mrq)2.34
Enterprise value/revenue 2.13
Enterprise value/EBITDA 11.72

Trading information

Stock price history

Beta (5Y monthly) 0.83
52-week change 3-10.64%
S&P500 52-week change 322.38%
52-week high 3118.57
52-week low 372.67
50-day moving average 382.91
200-day moving average 387.30

Share statistics

Avg vol (3-month) 351.49k
Avg vol (10-day) 328.2k
Shares outstanding 525.26M
Implied shares outstanding 625.59M
Float 8N/A
% held by insiders 137.43%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.4
Forward annual dividend yield 43.02%
Trailing annual dividend rate 32.07
Trailing annual dividend yield 32.61%
5-year average dividend yield 43.29
Payout ratio 458.67%
Dividend date 3N/A
Ex-dividend date 425 Jul 2023
Last split factor 21050:1000
Last split date 325 Jul 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 12.55%
Operating margin (ttm)16.45%

Management effectiveness

Return on assets (ttm)7.03%
Return on equity (ttm)12.67%

Income statement

Revenue (ttm)823.96M
Revenue per share (ttm)32.90
Quarterly revenue growth (yoy)-18.20%
Gross profit (ttm)N/A
EBITDA 139.51M
Net income avi to common (ttm)103.4M
Diluted EPS (ttm)4.09
Quarterly earnings growth (yoy)-39.30%

Balance sheet

Total cash (mrq)273.35M
Total cash per share (mrq)10.82
Total debt (mrq)25.03M
Total debt/equity (mrq)2.92%
Current ratio (mrq)3.46
Book value per share (mrq)33.92

Cash flow statement

Operating cash flow (ttm)154.01M
Levered free cash flow (ttm)115.66M